Patents by Inventor Omar Jameel Shah

Omar Jameel Shah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy for treating cancer and diagnostic assays for use therein
    Patent number: 8624027
    Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: January 7, 2014
    Assignee: AbbVie Inc.
    Inventors: Omar Jameel Shah, Yu Shen, Xiaoyu Lin, Mark Anderson, Xiaoli Huang, Junling Li, Leiming Li
  • Combination Therapy for Treating Cancer and Diagnostic Assays for Use Therein
    Publication number: 20100227838
    Abstract: The present disclosure relates to a combination of therapeutic agents for use in treating a patient a subject suffering from cancer. In addition, the present disclosure also relates to diagnostic assays useful in classification of patients for treatment with one or more therapeutic agents.
    Type: Application
    Filed: December 4, 2009
    Publication date: September 9, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Omar Jameel Shah, Yu Shen, Xiaoyu Lin, Mark Anderson, Xiaoli Huang, Junling Li, Leiming Li
  • METHOD OF TREATING CANCER
    Publication number: 20090203671
    Abstract: Methods of treating cancer in patients comprising administering thereto aurora kinase inhibitors and TRAIL (tumor necrosis factor (TNF)-related apoptosis inducing ligand) inhibitors is disclosed.
    Type: Application
    Filed: November 25, 2008
    Publication date: August 13, 2009
    Applicant: ABBOTT LABORATORIES
    Inventors: Keith B. Glaser, Omar Jameel Shah